KREBS BIOCHEMICALS & INDUSTRIES
Quarterly Results Analysis [Dec2024]
KREBS BIOCHEMICALS & INDUSTRIES Quarterly Results
Standalone | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹11 Cr | ₹13 Cr | ₹13 Cr | ₹12 Cr | ₹13 Cr | ₹15 Cr | ₹11 Cr | ₹11 Cr |
Expenses | ₹16 Cr | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹16 Cr | ₹13 Cr | ₹16 Cr |
Operating Income | ₹-5 Cr | ₹-3 Cr | ₹-2 Cr | ₹-3 Cr | ₹-2 Cr | ₹-1 Cr | ₹-3 Cr | ₹-5 Cr |
Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr |
Profit Before Tax | ₹-8 Cr | ₹-6 Cr | ₹-5 Cr | ₹-6 Cr | ₹-5 Cr | ₹-4 Cr | ₹-5 Cr | ₹-7 Cr |
Profit After Tax | ₹-8 Cr | ₹-6 Cr | ₹-5 Cr | ₹-6 Cr | ₹-5 Cr | ₹-4 Cr | ₹-5 Cr | ₹-7 Cr |
EPS | ₹-3.59 | ₹-2.67 | ₹-2.40 | ₹-2.71 | ₹-2.31 | ₹-1.66 | ₹-2.47 | ₹-3.22 |
Industry Peers & Returns | 1W | 1M | 1Y |
KREBS BIOCHEMICALS & INDUSTRIES | -3.5% | 5.4% | 33.8% |
SUN PHARMACEUTICAL INDUSTRIES | -2% | -0.8% | 16.6% |
CIPLA | 0.7% | 1.4% | 3.7% |
DR REDDYS LABORATORIES | 0.1% | -8.5% | 0.7% |
ZYDUS LIFESCIENCES | -0.9% | -1% | 24% |
DIVIS LABORATORIES | -2.7% | 3.5% | 66.7% |
MANKIND PHARMA | -1.7% | -3.2% | 12% |
TORRENT PHARMACEUTICALS | 2.8% | -1.5% | 23.1% |
LUPIN | 2.8% | 0.7% | 37% |
KREBS BIOCHEMICALS & INDUSTRIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -10.80 % |
Y-o-Y | -11.64 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹11 Cr | -10.80 | |
Sep2024 | ₹13 Cr | -0.26 | |
Jun2024 | ₹13 Cr | 7.65 | |
Mar2024 | ₹12 Cr | -7.74 | |
Dec2023 | ₹13 Cr | -12.85 | |
Sep2023 | ₹15 Cr | 40.72 | |
Jun2023 | ₹11 Cr | -7.68 | |
Mar2023 | ₹11 Cr | - |
KREBS BIOCHEMICALS & INDUSTRIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹-5 Cr | Negative | |
Sep2024 | ₹-3 Cr | Negative | |
Jun2024 | ₹-2 Cr | Negative | |
Mar2024 | ₹-3 Cr | Negative | |
Dec2023 | ₹-2 Cr | Negative | |
Sep2023 | ₹-1 Cr | Negative | |
Jun2023 | ₹-3 Cr | Negative | |
Mar2023 | ₹-5 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | -41.13% | Negative | |
Sep2024 | -21.08% | Negative | |
Jun2024 | -17.04% | Negative | |
Mar2024 | -26.01% | Negative | |
Dec2023 | -16.11% | Negative | |
Sep2023 | -6.05% | Negative | |
Jun2023 | -24.76% | Negative | |
Mar2023 | -40.35% | - |
KREBS BIOCHEMICALS & INDUSTRIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹-8 Cr | Negative | |
Sep2024 | ₹-6 Cr | Negative | |
Jun2024 | ₹-5 Cr | Negative | |
Mar2024 | ₹-6 Cr | Negative | |
Dec2023 | ₹-5 Cr | Negative | |
Sep2023 | ₹-4 Cr | Negative | |
Jun2023 | ₹-5 Cr | Negative | |
Mar2023 | ₹-7 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | -67.49 % | Negative | |
Sep2024 | -44.82 % | Negative | |
Jun2024 | -40.12 % | Negative | |
Mar2024 | -48.84 % | Negative | |
Dec2023 | -38.36 % | Negative | |
Sep2023 | -23.99 % | Negative | |
Jun2023 | -50.39 % | Negative | |
Mar2023 | -60.54 % | - |
KREBS BIOCHEMICALS & INDUSTRIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹-3.59 | Negative | |
Sep2024 | ₹-2.67 | Negative | |
Jun2024 | ₹-2.4 | Negative | |
Mar2024 | ₹-2.71 | Negative | |
Dec2023 | ₹-2.31 | Negative | |
Sep2023 | ₹-1.66 | Negative | |
Jun2023 | ₹-2.47 | Negative | |
Mar2023 | ₹-3.22 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD